The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.
- DOI
- 10.1002/1878-0261.13141
- Published
- 2022 Jun
- Container
- Molecular oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/1878-0261.13141,
title = {The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.},
author = {Triulzi T and Bianchini G and Di Cosimo S and Pienkowski T and Im YH and Bianchi GV and Galbardi B and Dugo M and De Cecco L and Tseng LM and Liu MC and Bermejo B and Semiglazov V and Viale G and de la Haba-Rodriguez J and Oh DY and Poirier B and Valagussa P and Gianni L and Tagliabue E},
year = {2022},
journal = {Molecular oncology},
doi = {10.1002/1878-0261.13141},
url = {https://doi.org/10.1002/1878-0261.13141}
}RIS
TY - JOUR TI - The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial. AU - Triulzi T AU - Bianchini G AU - Di Cosimo S AU - Pienkowski T AU - Im YH AU - Bianchi GV AU - Galbardi B AU - Dugo M AU - De Cecco L AU - Tseng LM AU - Liu MC AU - Bermejo B AU - Semiglazov V AU - Viale G AU - de la Haba-Rodriguez J AU - Oh DY AU - Poirier B AU - Valagussa P AU - Gianni L AU - Tagliabue E PY - 2022 JO - Molecular oncology DO - 10.1002/1878-0261.13141 UR - https://doi.org/10.1002/1878-0261.13141 ER -
APA
T, T., G, B., S, D. C., T, P., YH, I., GV, B., B, G., M, D., L, D. C., LM, T., MC, L., B, B., V, S., G, V., J, D. L. H., DY, O., B, P., P, V., L, G., & E, T. (2022). The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial.. Molecular oncology. https://doi.org/10.1002/1878-0261.13141
Source records
- pubmed · retrieved 2026-09-25T14:35:50.246Z